Table 3.
Multivariate analyses (logistic regressions) of factors associated with ≥ 1 episode of PHNH during the 14-day period
| Characteristic | Crude analyses | Adjusted for age and sex | Multiadjusteda | ||||||
|---|---|---|---|---|---|---|---|---|---|
| OR | 95% CI | P-value | OR | 95% CI | P-value | OR | 95% CI | P-value | |
| Sex (man) | 1.19 | 0.87–1.62 | 0.268 | 1.14 | 0.84–1.56 | 0.387 | 1.17 | 0.85–1.62 | 0.330 |
| Age (years) | 0.98 | 0.97–0.99 | < 0.001 | 0.98 | 0.97–0.99 | < 0.001 | 0.98 | 0.97–0.99 | 0.017 |
| LADA (yes)b | 0.41 | 0.25–0.67 | < 0.001 | 0.54 | 0.31–0.92 | 0.026 | 0.48 | 0.27–0.84 | 0.011 |
| Total daily dose of insulin (IU/kg/day) | 1.33 | 0.75–2.35 | 0.325 | 1.22 | 0.68–2.18 | 0.496 | 1.20 | 0.67–2.17 | 0.529 |
The multivariate logistic regression models included 755 cases, except those including the total daily dose of insulin, which included 735 cases
aAdjusted for sex, age, LADA diagnosis, and total daily dose of insulin
bSubtype of antibody-positive type 1 diabetes that is defined as adult-onset diabetes (> 30 years at diagnosis) with absence of insulin requirement for at least 6 months after diagnosis
OR, odds ratio. CI, confidence interval. IU, international units. LADA, latent autoimmune diabetes in adults